Clinical Trials and Bioavailability Research (ISSN: 2836-5836)

Description

Journal of Clinical Trials and Bioavailability Research (JCTBR) is a peer review Open Access journal whose primary aim is to develop knowledge about clinical trials and Bioavailability Research including existing or new policy in the relevant areas, impact of all types of clinical trials and related medical research methodologies. This journal for clinical studies expects outstanding contribution to disseminate novel information from the large pool of medical data generated every year and to receive high impact factor.
Safety and efficacy assessment is important in medical practices. Clinical trials are known as maintaining a set of regulations and procedures that determine the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. Regulations and guidelines are maintained globally for such issues along with testing of novel drugs, new medical procedure, new medical devices etc., where animal trials are followed by human trials. This peer reviewed journal covers a broad aspect of Clinical trials, Clinical practice guidelines, Clinical research and bioethics, Pre-clinical trials, Randomized trials, Protocols and other related topics justifying the title of the Journal.
Clinical Trials and Bioavailability Research journal includes a wide range of fields in its discipline to launch a common platform for the authors to make their contribution towards this journal of clinical research and the editorial office promises a peer review process for the submitted manuscripts for maintaining the quality of publishing. This clinical research and Bioavailability Research journal is a scholarly Open Access journal intend to publish valuable scientific information on the latest developments in the form of original articles, Protocols, Review articles, Case Reports, Short Communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.